Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Artra GroupTSE:6029 59 Receivables Turnover is 3.25 as of Dec. 2025. GuruFocus rates TSE:6029 with a GF Score™ of 59/100 and a GF Value™ of 円139.67 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 660 Healthcare Providers & Services companies, Artra Group ranks better than 67.73% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Artra Group's Revenue for the
three
months ended in Dec. 2025 was 円1,099 Mil. Artra Group's average Accounts Receivable for the
three
months ended in Dec. 2025 was 円339 Mil.
Hence, Artra Group's Receivables Turnover for the
three
months ended in Dec. 2025 was 3.25.
Artra Group (TSE:6029) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Artra Group Receivables Turnover Related Terms
Artra Group Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Artra Group's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:6029 vs HCA, THC, DVA: Receivables Turnover Comparison
For the Medical Care Facilities subindustry, Artra Group's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Artra Group Receivables Turnover vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Artra Group's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Artra Group's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Artra Group (TSE:6029) has a Receivables Turnover of 3.25 as of Dec. 2025. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Artra Group and its competitors. According to the industry distribution chart, Artra Group ranks #213 out of 660 companies in the Healthcare Providers & Services industry, placing it in the top 32.3%.
Is Artra Group's Receivables Turnover too high?
Artra Group's current Receivables Turnover is 3.25. The Healthcare Providers & Services industry median Receivables Turnover is 7.96. Artra Group's value of 3.25 is 59.2% below this industry median. Based on the distribution chart, Artra Group ranks #213 out of 660 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Artra Group has a GF Score™ of 59/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Artra Group's Receivables Turnover compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Artra Group ranks #213 out of 660 companies for Receivables Turnover. This puts Artra Group in the upper half of its industry. The industry median Receivables Turnover is 7.96. Artra Group's value of 3.25 is 59.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Healthcare Providers & Services company?
The median Receivables Turnover among Healthcare Providers & Services companies is 7.96, based on 660 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Artra Group's current Receivables Turnover of 3.25 is 59.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Artra Group and its competitors. For the Healthcare Providers & Services industry, the median Receivables Turnover is 7.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Artra Group's current Receivables Turnover is 3.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Artra Group stock overvalued right now?
Based on GuruFocus' analysis, Artra Group (TSE:6029) is currently considered Significantly Overvalued. The stock's GF Value™ is 円139.67, compared to a current price of 円195.00 — trading 39.6% above its estimated fair value. The current Receivables Turnover is 3.25 and 59.2% below the Healthcare Providers & Services industry median of 7.96. Artra Group's overall GF Score™ is 59/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Artra Group (TSE:6029), the current Receivables Turnover is 3.25 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Artra Group (TSE:6029) Overvalued in 2026?
Based on GuruFocus' analysis, Artra Group stock appears to be overvalued.
The current stock price of 円195.00 is trading 39.6% above its estimated GF Value™ of 円139.67.
GuruFocus considers Artra Group to be Significantly Overvalued.
Key valuation signals for TSE:6029:
Receivables Turnover: 3.25
GF Value™: 円139.67 vs. price of 円195.00 (39.6% above fair value)
Industry Position: 59.2% below the Healthcare Providers & Services median (#213 of 660)
No single metric tells the full story. See the TSE:6029 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Artra Group Corp is engaged in the healthcare support business, providing services that assist the operation and management of clinics and related facilities. The group has two reportable segments: Acupuncture & Orthopedic Clinic Support and Toy Sales Business. The Acupuncture and Orthopedic Clinic Support segment is involved in supporting acupuncture and orthopedic clinics through services such as bone setting chains, provision of equipment and consumables, Attra billing services, HONEY-STYLE, and nursing care support. The Toy Sales segment focuses on the sale of toys, stationery, and other related products.
59GF Score
Get the complete analysis for TSE:6029
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:6029 has been successfully added to your 
